Intravenous tirofiban in acute ischemic stroke patients not receiving reperfusion treatments: A systematic review and meta-analysis of randomized controlled trials

Key Points

• Tirofiban may improve clinical outcomes in acute ischemic stroke patients, indicating its possible effectiveness.
• In the analysis of multiple randomized controlled trials, tirofiban presented beneficial changes in functional status in these patients.
• Systematic review and meta-analysis based on randomized controlled trials focused on those not receiving reperfusion treatments.
• Highlighting the need for further investigation into tirofiban's role in standard treatment guidelines for stroke management.